Rosiglitazone Maleate Patent Expiration
Rosiglitazone Maleate is Used for managing and improving glycemic control in patients with type 2 diabetes mellitus. It was first introduced by Woodward Pharma Services Llc
Rosiglitazone Maleate Patents
Given below is the list of patents protecting Rosiglitazone Maleate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Avandia |
US7358366 (Pediatric) | Thiazolidinedione derivative and its use as antidiabetic |
Oct 19, 2020
(Expired) | Woodward |
| Avandia | US7358366 | Thiazolidinedione derivative and its use as antidiabetic |
Apr 19, 2020
(Expired) | Woodward |
| Avandia |
US6288095 (Pediatric) | Compounds |
Aug 11, 2017
(Expired) | Woodward |
| Avandia | US6288095 | Compounds |
Feb 11, 2017
(Expired) | Woodward |
| Avandia |
US5741803 (Pediatric) | Substituted thiazolidinedionle derivatives |
Oct 21, 2015
(Expired) | Woodward |
| Avandia | US5741803 | Substituted thiazolidinedionle derivatives |
Apr 21, 2015
(Expired) | Woodward |
Rosiglitazone Maleate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List